Clinical Trial Update: A Study to Evaluate Safety and Efficacy of rhNGF Eye Solution vs Vehicle in Patients With Moderate to Severe Dry Eye [Phase 2]

View source ↗

Summary

Phase 2 trial of rhNGF eye solution for moderate to severe dry eye completed; safety and efficacy results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• rhNGF eye solution (recombinant human nerve growth factor (rhNGF))

Snippet

Sponsor: Dompé Farmaceutici S.p.A | Conditions: Dry Eye Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2022-02-08